Hem › Akut myeloid leukemi › Kalifornien › San Francisco
Kliniska studier för Akut myeloid leukemi i San Francisco, CA
12 studier för Akut myeloid leukemi söker deltagare vid platser i och runt San Francisco (inom ca 30 miles). Öppna en studie för att se vem som kan delta och hur du kontaktar studieteamet.
Officiell studietext (engelska)
Rekryterar du till en studie? Visa den högst upp på sidan – $99 i 30 dagar →
MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)
RekryterarFas 2
- Kaiser Permanente-San Francisco, San Francisco
- UCSF Medical Center-Parnassus, San Francisco
Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- UCSF Medical Center-Parnassus, San Francisco
Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- UCSF Medical Center-Parnassus, San Francisco
Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- UCSF Medical Center-Parnassus, San Francisco
Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)
RekryterarFas 2
- Kaiser Permanente-San Francisco, San Francisco
- UCSF Medical Center-Parnassus, San Francisco
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
RekryterarFas 3
- UCSF Medical Center-Mission Bay, San Francisco
Revumenib in Combination With Azacitidine + Venetoclax in Patients NPM1-mutated or KMT2A-rearranged AML
RekryterarFas 3
- US-San Francisco CA-UCSF, San Francisco
Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)
RekryterarFas 3
- US-San Francisco CA-UCSF, San Francisco
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
RekryterarFas 1/2
- UCSF Medical Center-Mission Bay, San Francisco
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
RekryterarFas 3
- Benioff Children's Hospital - Mission Bay, San Francisco
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
RekryterarFas 1
- University of California San Francisco, San Francisco
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
RekryterarObservationsstudie
- UCSF (Peds), San Francisco
Akut myeloid leukemi-studier i andra städer
- Houston, TX85 studier
- New York City, NY51 studier
- Boston, MA44 studier
- Seattle, WA41 studier
- Baldwin Park, CA40 studier
- Columbus, OH35 studier
- Philadelphia, PA34 studier
- Durham, NC33 studier
- Atlanta, GA31 studier
- Tampa, FL29 studier
- Chicago, IL26 studier
- Portland, OR25 studier
Andra studier i San Francisco
- Prostatacancer45 studier
- Bröstcancer43 studier
- Icke-småcellig lungcancer36 studier
- Cancer (alla typer)35 studier
- Hjärtsvikt29 studier
- Metastaserande cancer28 studier
- Lungcancer22 studier
- Melanom22 studier
- Bukspottkörtelcancer20 studier
- Äggstockscancer19 studier
- Kolorektal cancer18 studier
- Hjärt-kärlsjukdom18 studier
Från ClinicalTrials.gov, data hämtad 6 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.